HealthEdge Investment Partners announced that it has completed the sale of LifeSync, a developer, manufacturer, and marketer of disposable and reusable patient monitoring devices and connections sold to hospitals and other high acuity settings. LifeSync was acquired by Amphenol (APH).
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on APH:
- Third Point buys Capital One, cuts Microsoft in Q4
- Amphenol Corporation’s Financial Stability Threatened by Market Volatility
- Amphenol Bolsters Market Position with Strategic Acquisitions
- Amphenol Corp’s Q4 2024 Earnings: Record Growth Amid Challenges
- Trump Trade: President blasts EU regulators for targeting U.S. tech companies